Images List Premium Download Classic

Uterine Fibroids

Uterine Fibroids-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Selective progesterone receptor modulator (sprm) regimen
Bayer Pharma Aktiengesellschaft
June 07, 2018 - N°20180155388

The invention is directed to a pharmaceutical composition comprising a progesterone receptor antagonist namely (11β,17β)-17-hydroxy-11-[4-(methylsulphonyl)phenyl]-17-(pentafluoroethy)estra-4,9-dien-3-one for the treatment and/or prophylaxis of uterine fibroids (myomas, uterine leiomyoma) that is administered to a patient diagnosed with uterine fibroids following a specific regimen. Additionally, the invention is ...
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
May 03, 2018 - N°20180118663

This invention provides novel 3-amino propanamide selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (ar-fl) including pathogenic or resistance ...
Pigment epithelium derived factor (pedf) for the treatment of uterine fibroids
Ramot At Tel-aviv University Ltd.
February 15, 2018 - N°20180043001

A method of treating uterine fibroid in a subject in need thereof is provided. The method comprising administering to the subject a therapeutically effective amount of pigment epithelium-derived factor (pedf), thereby treating the uterine fibroid in the subject..
Uterine Fibroids Patent Pack
Download + patent application PDFs
Uterine Fibroids Patent Applications
Download + Uterine Fibroids-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Uterine Fibroids-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
December 28, 2017 - N°20170368003

This invention is directed to pyrrole, pyrazole, imidazole, triazole, and morpholine based selective androgen receptor degrader (sard) compounds including heterocyclic anilide rings and their synthetic precursors, r-isomers, and non-hydroxylated and/or non-chiral propanamides, and pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, triple negative breast cancer, other cancers expressing the androgen receptor, ...
Treatment method and product for uterine fibroids using purified collagenase
North Carolina Central University
November 23, 2017 - N°20170333356

The invention relates to compositions and methods for treating uterine fibroids, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.. .
Method for treating uterine fibroids
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services
August 31, 2017 - N°20170246189

The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-n,n-dimethylamino-phenyl) -19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/...
Uterine Fibroids Patent Pack
Download + patent application PDFs
Uterine Fibroids Patent Applications
Download + Uterine Fibroids-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Uterine Fibroids-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
May 18, 2017 - N°20170137374

This invention provides novel 3-amino propanamide selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (ar-fl) including pathogenic or resistance ...
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
April 06, 2017 - N°20170095446

This invention provides novel indole, indazole, benzimidazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyper androgenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen ...
Methods of administering elagolix
Abbvie Inc.
March 02, 2017 - N°20170056403

The present disclosure relates to the use of gnrh receptor antagonists used in the treatment of endometriosis or uterine fibroids. In particular, the present disclosure describes a method of treating endometriosis or uterine fibroids, where the method involves the administration of elagolix, and where the method may further involve the co-administration of rifampin or ketoconazole..
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
February 23, 2017 - N°20170050921

This invention provides novel 3-amino propanamide selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, androgenic alopecia or other hyperandrogenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), and uterine fibroids, and to methods for reducing the levels of androgen receptor-full length (ar-fl) including pathogenic or resistance ...
Selective androgen receptor degrader (sard) ligands and methods of use thereof
University Of Tennessee Research Foundation
February 02, 2017 - N°20170029370

This invention provides novel indole, indazole, benzimidazole, indoline, quinolone, isoquinoline, and carbazole selective androgen receptor degrader (sard) compounds, pharmaceutical compositions and uses thereof in treating prostate cancer, advanced prostate cancer, castration resistant prostate cancer, other ar-expressing cancers, androgenic alopecia or other hyper androgenic dermal diseases, kennedy's disease, amyotrophic lateral sclerosis (als), abdominal aortic aneurysm (aaa), and uterine fibroids, and to ...
System and method for three-dimensional quantitative evaluaiton of uterine fibroids
Koninklijke Philips N.v.
November 17, 2016 - N°20160335770

A system (100) and method which assess the results of uterine fibroid embolization. A fibroid lesion is three-dimensionally segmented by a segmentation module (110) on contrast-enhanced arterial phase mri or cbct images and a differentiation process performed by a subtraction module (114) identifies actual contrast enhancement from background enhancement.
Surgical capture device and methods of use
Espiner Medical Ltd.
May 19, 2016 - N°20160135798

A surgical capture device is described that is configured to sequester tissue from a surgical cavity while the tissue is morcellated, or otherwise reduced in size. The capture device includes a side conduit that provides access to the interior of the device so that the tissue can be visualized during the morcellation process.
Uterine Fibroids Patent Pack
Download + patent application PDFs
Uterine Fibroids Patent Applications
Download + Uterine Fibroids-related PDFs
For professional research & prior art discovery
inventor
  • + full patent PDF documents of Uterine Fibroids-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Method for treating uterine fibroids
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services
January 28, 2016 - N°20160022698

The invention relates to a method for treating uterine fibroids, which method comprises administering to a patient in need thereof, an effective amount of 17α-acetoxy-11β-[4-n,n-dimethylamino-phenyl)-19-norpregna-4,9-diene-3,20-dione (ulipristal) or any metabolite thereof. More particularly, the method is useful for reducing or stopping bleeding in a patient afflicted with uterine fibroids, and/...
Herbal composition and a method of treating uterine fibroids
Kang Li Biotech Co., Ltd.
January 07, 2016 - N°20160000846

The invention discloses an herbal composition of treating uterine fibroid. The herbal composition comprises antrodia cinnamomea, astragalus membranaceus, and leonurus japonicus; wherein the weight percentages of antrodia cinnamomea, astragalus membranaceus and leonurus japonicus are 25 to 75%, 20.8 to 62.5% and 4.2 to 12.5% by weight of the formula, respectively.
Loading